The pathologic and immunologic effects of inhaled acrolein in rats.
Four groups of 40 male Sprague-Dawley rats each were exposed by inhalation to target concentrations of 0, 0.1, 1.0, and 3.0 ppm of acrolein 6 h/day, 5 days/week for 3 weeks. Subsequent changes in local pulmonary immunity were determined by examining the number of antibody plaque-forming cells in the lung-associated lymph nodes following intratracheal immunization with sheep red blood cells. Separate groups of rats were evaluated for blastogenic responsiveness to phytohemagglutinin-P and Salmonella typhimurium antigen using spleen- and lung-associated lymph node cells. In vivo resistance was evaluated utilizing acrolein-exposed rats subsequently challenged with intravenous Listeria monocytogenes. Local pulmonary antibody responsiveness was not affected by acrolein exposure. Lymphocyte blastogenesis and resistance to Listeria challenge were not altered. Body weights and spleen weights were decreased in the 3 ppm-exposed group only. Microscopic examination of the nasal turbinates revealed acrolein-induced exfoliation, erosion, and necrosis of the respiratory epithelium as well as squamous metaplasia, however, lung histology was not affected. Thus at environmental concentrations, acrolein toxicity appeared to be confined to local nasal pathologic changes with no alterations in lung histology or immune function.
IIT Research Institute, Life Sciences Research, Chicago, IL 60616.
C L
CL
Leach
N S
NS
Hatoum
H V
HV
Ratajczak
J M
JM
Gerhart
D000171:Acrolein / Q000633:toxicity*; D000280:Administration, Inhalation; D000447:Aldehydes / Q000633:toxicity*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D007109:Immunity / Q000187:drug effects*; D008168:Lung / Q000187:drug effects; D008297:Male; D009296:Nasal Cavity / Q000187:drug effects / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains; D012137:Respiratory System / Q000187:drug effects*; D014420:Turbinates / Q000473:pathology
D000447:Aldehydes; D000171:Acrolein